| Financial Year |
March 31 2023 |
| Monetary Funds |
169,841,469.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
981,041.25 |
| Accounts Receivable |
246,171,678.89 |
| Advances to Suppliers |
14,772,763.73 |
| Other Receivables |
5,753,430.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
387,989,350.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,611,508.39 |
| Total Current Assets |
855,105,577.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,277,836.94 |
| Investment Properties |
-- |
| Fixed Assetes |
143,999,047.87 |
| Under-construction Projects |
361,421,821.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
119,511,935.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,450.97 |
| Deferred Income Tax Assets |
25,252,631.50 |
| Other Non-Current Assets |
1,948,167.74 |
| Sub-Total of Non-Current Assets |
777,048,309.21 |
| Total Assets |
1,632,153,886.40 |
| Short-Term Loans |
119,711,829.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,896,407.47 |
| Accounts Payable |
51,558,685.29 |
| Accounts Received In Advance |
587,010.01 |
| Employee Compensation Payable |
2,167,855.11 |
| Taxes Payable |
8,820,291.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,822,216.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,302,546.38 |
| Other Current Liabilities |
13,764,760.72 |
| Sub-Total of Current Liabilities |
293,975,916.03 |
| Long-term Loans |
30,924,852.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
30,000,000.00 |
| Sub-Total of Non-Current Liabilities |
63,561,039.27 |
| Total Liabilities |
357,536,955.30 |
| Paid-In Capital(Or Share Stock) |
191,360,000.00 |
| Capital Surplus |
295,982,263.40 |
| Surplus Reserve |
69,460,684.08 |
| LESS:Treasury Stock |
15,004,931.00 |
| Undistributed Profits |
654,597,240.92 |
| Minority Stockholder's Interest |
78,926,745.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,195,690,185.25 |
| Owner's Equity（Stockholder's Equity） |
1,274,616,931.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,632,153,886.40 |
